Join us at DDW25 to explore how ClearNote Health is harnessing the power of the epigenome to drive early pancreatic cancer detection and transform patient outcomes.

📍 Visit us at booth #5525 to learn more about the @Avantect Pancreatic Cancer Test – a simple, cell-free DNA blood test that aims to enable earlier diagnosis and improve patient outcomes.

Plus, don’t miss the opportunity to connect with our CSO, Dr. Samuel Levy, to discuss the latest in liquid biopsy innovation, biomarker discovery, and new avenues for collaboration.

We look forward to seeing you there!

ClearNote Health
Privacy Overview

We use cookies, subject to your consent, to analyze the use of our website and to ensure you get the best experience. Third parties with whom we collaborate can also install cookies in order to show you personalized advertisements on other websites. Read our cookie policy for more information.
Read our privacy policy to understand how ClearNote Health handles personal information that we collect through our digital properties that link to this Privacy Policy, including our website and other activities described in the privacy policy.